Raymond James Financial »

Akero Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-06-30 $72k 1.4k 53.37
2025-03-31 $1.5M 37k 40.49

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding Akero Therapeutics

Henderson Group
General Atlantic
BlackRock
Rtw Investments
Vanguard Group
Wellington Management Company
Deep Track Capital
venBio Select Advisor
State Street Corporation
Bellevue Group
Point72 Asset Management
Alkeon Capital Management
Geode Capital Management
Alliancebernstein
Marshall Wace

View all funds holding Akero Therapeutics